ICRP publication 118: ICRP statement on tissue reactions and early and late effects of radiation in normal tissues and organs–threshold doses for tissue reactions in a …
FA Stewart, AV Akleyev, M Hauer-Jensen, JH Hendry… - Annals of the ICRP, 2012 - Elsevier
This report provides a review of early and late effects of radiation in normal tissues and
organs with respect to radiation protection. It was instigated following a recommendation in …
organs with respect to radiation protection. It was instigated following a recommendation in …
Clinical radiation nephropathy
JR Cassady - International Journal of Radiation Oncology* Biology …, 1995 - Elsevier
An analysis of the normal tissue effects of irradiation of the kidney is presented. Various
clinical syndromes resulting from treatment are described as well as the potential cellular …
clinical syndromes resulting from treatment are described as well as the potential cellular …
[HTML][HTML] Targeted total marrow irradiation using three-dimensional image-guided tomographic intensity-modulated radiation therapy: an alternative to standard total …
JYC Wong, A Liu, T Schultheiss, L Popplewell… - Biology of Blood and …, 2006 - Elsevier
Total body irradiation (TBI) is an important part of bone marrow transplantation conditioning
regimens. In TBI, dose escalation is difficult, because of associated normal organ toxicities …
regimens. In TBI, dose escalation is difficult, because of associated normal organ toxicities …
[HTML][HTML] Chronic kidney disease after hematopoietic cell transplantation: a systematic review
Advances in hematopoietic cell transplantation (HCT) have broadened its indications for use
and resulted in more long‐term HCT survivors. Some survivors develop chronic kidney …
and resulted in more long‐term HCT survivors. Some survivors develop chronic kidney …
Acute renal failure in the setting of bone marrow transplatation
RA Zager - Kidney international, 1994 - Elsevier
Discussion DR. RIctiAjw A. ZAGER (Professor of Medicine, Fred Hutchinson Cancer
Research Center, Seattle, Washington): Worldwide, approx-imately 5000 bone marrow …
Research Center, Seattle, Washington): Worldwide, approx-imately 5000 bone marrow …
Acute kidney injury and CKD associated with hematopoietic stem cell transplantation
ADM Renaghan, EA Jaimes, J Malyszko… - Clinical Journal of the …, 2020 - journals.lww.com
Hematopoietic stem cell transplantation is a life-saving therapy for many patients with
cancer, as well as patients with some nonmalignant hematologic disorders, such as aplastic …
cancer, as well as patients with some nonmalignant hematologic disorders, such as aplastic …
Chronic kidney disease in long-term survivors of hematopoietic cell transplant
S Hingorani, KA Guthrie, G Schoch, NS Weiss… - Bone marrow …, 2007 - nature.com
We conducted a cohort study to identify risk factors of chronic kidney disease (CKD) among
long-term survivors of hematopoietic cell transplant (HCT). We studied 1635 patients …
long-term survivors of hematopoietic cell transplant (HCT). We studied 1635 patients …
Extensive 177Lu-PSMA radioligand therapy can lead to radiation nephropathy with a renal thrombotic microangiopathy–like picture
H Schäfer, S Mayr, M Büttner-Herold, K Knorr… - European Urology, 2023 - Elsevier
Lutetium-177 prostate-specific membrane antigen (177 Lu-PSMA) radioligand therapy is an
option that is increasingly being used for treatment of metastatic castration-resistant prostate …
option that is increasingly being used for treatment of metastatic castration-resistant prostate …
Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease.
R Miralbell, S Bieri, B Mermillod, C Helg… - Journal of clinical …, 1996 - ascopubs.org
PURPOSE To evaluate retrospectively the cumulative risk probability and factors correlated
with renal dysfunction after allogeneic bone marrow transplantation (BMT). PATIENTS AND …
with renal dysfunction after allogeneic bone marrow transplantation (BMT). PATIENTS AND …
Rhenium 188–labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute …
D Bunjes, I Buchmann, C Duncker… - Blood, The Journal …, 2001 - ashpublications.org
The conditioning regimen prior to stem cell transplantation in 36 patients with high-risk acute
myeloid leukemia (AML) and myelodysplastic syndrome (MDS) was intensified by treating …
myeloid leukemia (AML) and myelodysplastic syndrome (MDS) was intensified by treating …